EPS Bio Technology Corp. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 109.583 million compared to TWD 102.352 million a year ago. Operating income was TWD 15.190 million compared to TWD 10.398 million a year ago. Net income was TWD 11.671 million compared to TWD 6.351 million a year ago. Basic earnings per share was TWD 0.49 compared to TWD 0.27 a year ago. For the nine months, sales was TWD 359.622 million compared to TWD 322.372 million a year ago. Operating income was TWD 39.620 million compared to TWD 18.809 million a year ago. Net income was TWD 29.936 million compared to TWD 14.850 million a year ago. Basic earnings per share was TWD 1.26 compared to TWD 0.62 a year ago. Diluted earnings per share was TWD 1.25 compared to TWD 0.62 a year ago.